{"product_id":"novel-therapeutic-targets-for-antiarrhythmic-drugs-9780470261002","title":"Novel Therapeutic Targets for Antiarrhythmic Drugs","description":"\u003cp\u003e • Author(s): George Edward Billman\u003cbr\u003e • Publisher: Wiley\u003cbr\u003e • Publisher Imprint: Wiley\u003cbr\u003e • BISAC: Cardiology\u003c\/p\u003e\u003cp\u003e\u003c\/p\u003e\u003cp\u003e\u003cb\u003ePROFILES POTENTIAL TREATMENT APPROACHES FOR CARDIAC ARRHYTHMIAS\u003c\/b\u003e \u003c\/p\u003e\u003cp\u003eCardiac arrhythmias of ventricular origin are responsible for the deaths of nearly half a million Americans each year while atrial fibrillation accounts for about 2.3 million cases per year, a rate that is projected to increase 2.5 fold over the next half century. Effectively managing these cardiac rhythm disorders remains a major challenge for both caregivers and the pharmaceutical industry. Filling a gap in the current literature, \u003ci\u003eNovel Therapeutic Targets for Antiarrhythmic Drugs\u003c\/i\u003e presents the latest treatments for cardiac arrhythmias alongside comprehensive presentations of basic cardiac physiology and pharmacology. \u003c\/p\u003e\u003cp\u003eWritten by leading experts in their research areas, this invaluable resource offers both practitioners and researchers a one-stop guide that brings together previously dispersed information. The text consists of four sections:  *\u003cb\u003eSection One\u003c\/b\u003e comprehensively reviews basic cardiac electrophysiology, the mechanisms responsible for arrhythmias in the setting of ischemia, and basic pharmacology of antiarrhythmic drugs. *\u003cb\u003eSection Two\u003c\/b\u003e addresses safety pharmacology, including the concept of \"repolarization reserve,\" safety challenges, and regulatory issues for the development of novel antiarrhythmic drugs. *\u003cb\u003eSection Three\u003c\/b\u003e describes several novel pharmacological targets for antiarrhythmic drugs, including both ion channel and non-ion channel targets. *\u003cb\u003eSection Four\u003c\/b\u003e describes promising non-pharmacological antiarrhythmic interventions including selective cardiac neural disruption or nerve stimulation, aerobic exercise training, and diet (omega-3 fatty acids).  \u003c\/p\u003e\u003cp\u003eOffering an unparalleled look at the current state and future direction of cardiac arrhythmia treatment, \u003ci\u003eNovel Therapeutic Targets for Antiarrhythmic Drugs\u003c\/i\u003e provides an important resource to advanced students, working researchers, and busy professionals alike.\u003c\/p\u003e","brand":"Wiley","offers":[{"title":"Hardcover","offer_id":45201890476183,"sku":"9780470261002","price":18486.0,"currency_code":"INR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0666\/3471\/1191\/files\/9780470261002.webp?v=1767307683","url":"https:\/\/atlanticbooks.com\/products\/novel-therapeutic-targets-for-antiarrhythmic-drugs-9780470261002","provider":"Atlantic Books","version":"1.0","type":"link"}